Cheryl Willman, Enterprise Executive Director at Mayo Clinic Comprehensive Cancer Center, shared Mayo Clinic‘s post on LinkedIn, adding:
“Congratulations to Ajit Goenka and our Mayo Clinic Comprehensive Cancer Center investigators on this transformative achievement: an AI algorithm that can detect pancreatic cancer 1-3 years before it is detected on standard CT scans! This transformative REDMOD algorithm is now being tested across Mayo Clinic in one of the nation’s first clinical trials for early detection of pancreatic cancer (NCT07324096; NCI-2025-09279).
This work is enabled by the generous support of our benefactors (The Hoveida Family Foundation; The Heidi Diercks Krause Fund for AI Innovation in Cancer), our superb partnership with our many colleagues at NVIDIA, and the Mayo Clinic AI Program. We are now designing the clinical pathway to move from early detection, to early surgical and theranostics intervention, to cure, bringing new hope and healing to patients we serve from across the world.
Thank you to the many colleagues and collaborators who made this achievement possible!”
Quoting Mayo Clinic’s post:
“Mayo Clinic’s Radiomics-Based Early Detection Model (REDMOD) has been named one of TIME’s Best Inventions of 2026, recognizing an innovative approach to detecting pancreatic cancer earlier.
REDMOD uses AI to analyze CT scans for subtle changes in pancreatic tissue texture that may be detectable up to three years before a pancreatic cancer diagnosis.
With support from the Hoveida Family Foundation and high-performance graphics processing unit (GPU) technology from NVIDIA, a multidisciplinary team at Mayo Clinic Comprehensive Cancer Center is advancing an innovation with the potential to transform pancreatic cancer detection.”
You can also read: 5 Pancreatic Cancer Trials to Watch at ESMO 2026
